Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$149,975
-$11,058 QoQ
Shares Held
15,921
-19.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#148
of 263 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OXFORD ASSET MANAGEMENT LLP holds $5,324,165 across 21 Biotechnology names. NVAX ranks #16 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,265 | $788,778 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
16,221 | $632,781 | |
| 3 | KARD |
Kardigan, Inc.
|
18,378 | $438,315 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,364 | $410,604 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,050 | $383,924 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
5,478 | $313,451 | |
| 7 | BHVN |
Biohaven Ltd.
|
17,871 | $265,920 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
31,064 | $243,852 |
All Filings in NVAX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,975 | 15,921 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $161,033 | 19,783 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $144,553 | 21,511 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||